Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...
While a U.S. federal judge ordered the Trump administration to reverse the funding freeze, the effect isn’t immediate.
AstraZeneca (AZN) has reported positive results from an analysis of its NIAGARA Phase 3 study of Imfinzi in the treatment of ...
In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population ...
Vitamin D supplementation during TB treatment improves patient symptoms, but does not accelerate the clearance of TB bacteria.
According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...
A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...
A symptom of COVID is the loss of taste or smell. Tuberculosis has a longer incubation period, and the symptoms have a much ...
8d
HealthDay on MSNThree All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TBThree all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-susceptible, ...
New Jersey is experiencing a similar increase in cases and has a TB incidence rate above the national average. While TB isn’t ...
In a major breakthrough, an international clinical trial has identified three new safe and effective drug regimens for tuberculosis resistant to rifampin, the most potent first-line antibiotic for TB ...
Health officials in Kansas have reported a tuberculosis outbreak in the northeastern part of the state, with 67 active cases since 2024, marking one of the largest outbreaks in recorded history ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results